Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | Japan | 01 Aug 2011 | |
HLA-A2 Positive Non-Small Cell Lung Cancer | Phase 1 | Japan | 01 Feb 2010 |
Phase 1/2 | 30 | Allogeneic tumor vaccine expressing IL-2 and IFN-γ | afvqxrnhoq(wqbfdyrdtq) = tcwhgenbdw lblfnqjtvs (bzktfzthte ) View more | Positive | 20 Jun 2007 |